Dr. Yilie Liao, Zhongshan Institute for Drug Discovery (ZIDD), China
Yilie Liao is an accomplished scientist specializing in metabolic research and integrative biology. Currently, she serves as an Assistant Research Scientist at the Zhongshan Institute for Drug Discovery under the Shanghai Institute of Materia Medica, part of the Chinese Academy of Sciences. With a Ph.D. in Biology from Tsinghua University, Yilie has a rich background in life sciences, particularly focusing on metabolic disease, neurodevelopment, and tumorigenesis. Her research, conducted in collaboration with leading institutions, including Duke-NUS Medical School, delves into metabolic reprogramming, revealing significant insights into the biological mechanisms underlying health and disease. She is recognized for her innovative approach, evidenced by her pioneering work in metabolic pathways and proteomic studies. Through her dedication to research and collaboration, Yilie continues to push the boundaries of biological sciences, making notable contributions to the understanding and potential treatments for complex metabolic conditions.
Suitability for the Research for Best Researcher Award
Yilie Liaoโs dedication to addressing vital biological questions in metabolic health and his breadth of expertise in both technical and conceptual aspects of biology position him as an exceptional candidate for the Research for Best Researcher Award. His innovative findings, technical versatility, and contributions to high-impact publications underscore his potential for continued advancements in biology.
ย ย Educationย
Yilie Liao obtained her Ph.D. in Biology from the School of Life Sciences at Tsinghua University in 2020, where she conducted groundbreaking research under the mentorship of Dr. Suneng Fu. Her doctoral studies focused on metabolic reprogramming in metabolic diseases and neural development. Previously, she earned her B.Sc. in Biological Science from Nanjing Agricultural University in 2013. Her undergraduate education laid the foundation for her interest in integrative biology and metabolic research. Throughout her academic journey, Yilie acquired a robust skill set, encompassing molecular biology techniques, data analysis, and metabolomic profiling. Her proficiency in multi-omics data analysis, combined with a strong foundation in biological sciences, has enabled her to explore complex biochemical pathways and cellular processes. Her educational background reflects her commitment to advancing scientific knowledge and tackling complex issues in metabolic diseases and cellular biology.
ย ย Experience
Yilie Liaoโs research career spans several prestigious institutions and roles, each contributing to her expertise in metabolic biology. She is currently an Assistant Research Scientist at Zhongshan Institute for Drug Discovery under the Shanghai Institute of Materia Medica. From 2021 to 2023, she worked as a Postdoctoral Fellow at Bioland Laboratories, investigating neurodevelopmental and metabolic disease mechanisms under Prof. Peng Li. In 2022, she was a visiting researcher at Duke-NUS Medical School, exploring novel metabolic pathways with renowned scientists Prof. Weiping Han and Dr. Alfred Sun. Her projects have included identifying SLC transporters in the central nervous system and studying metabolic substrates impacting liver and brain health. Through these roles, Yilie has acquired extensive experience in experimental design, data mining, and integrative biology, making her a leading expert in her field with substantial contributions to metabolic disease research.
ย Awards and Honorsย
Yilie Liaoโs contributions to metabolic biology and her dedication to advancing scientific understanding have earned her numerous accolades. Her work on hepatic lipogenesis and metabolic reprogramming has been recognized with prestigious awards from leading scientific societies, highlighting her impact in biomedical research. She has received notable recognition from the Chinese Academy of Sciences for her innovative work in translational research and metabolic disease. As a testament to her expertise, she has been a recipient of research grants supporting her studies on cellular metabolism, neurodevelopment, and tumorigenesis. Yilieโs publications in high-impact journals such as Cell Metabolism and Hepatology further underscore her prominence in the field. Her academic and professional honors reflect her commitment to scientific excellence and her potential to drive significant advancements in biological and metabolic research.
ย Research Focus
Yilie Liaoโs research centers on uncovering the intricate mechanisms of metabolic reprogramming in health and disease. She investigates how metabolic pathways influence conditions such as obesity, neurodevelopmental disorders, and cancer, with a particular focus on the role of amino acids in hepatic lipogenesis. Her recent work explores SLC transportersโ influence in the central nervous system and their impact on brain functions. Additionally, her research extends to the identification of metabolic markers in Alzheimerโs disease, using single-cell sequencing to reveal early dysfunctions. She is also involved in studying tumor microenvironment metabolic changes, with implications for early diagnosis and treatment of liver cancer. Through her work, Yilie aims to provide insight into metabolic diseases and develop novel therapeutic approaches that address metabolic imbalances, contributing to the broader field of translational medicine.
Publication Top Notes
Amino acid is a major carbon source for hepatic lipogenesis
Dr. Guanhu Yang, MD, PhD, LAc, is a distinguished figure in Traditional Chinese Medicine (TCM) with extensive experience spanning over three decades in both clinical practice and academia. Based in Mason, Ohio, he holds a PhD from Kanazawa Medical University in Japan, focusing on lung injury and repair. He also earned an MS from Nanjing University of Chinese Medicine and a medical degree from Zhejiang Chinese Medical University. Dr. Yang serves as a professor and doctoral supervisor and holds editorial roles in international medical journals. As the President of the Chinese Medicine Luobing Society of America and an executive leader in numerous TCM associations globally, Dr. Yang is dedicated to advancing integrative medicine. His clinical expertise and research contributions in TCM, particularly in acupuncture and herbology, continue to shape modern understanding of holistic healthcare.
Summary of Suitability for the Research for Research Excellence Award
Dr. Guanhu Yang, with his MD and PhD background in Traditional Chinese Medicine (TCM) and a substantial focus on lung injury and repair, presents a commendable profile for the “Research for Research Excellence Award.” His career spans more than three decades across multiple countries, including China, Japan, Canada, Switzerland, and the United States, where he has contributed as a clinician, academician, researcher, and leader. Dr. Yang has held diverse positions, such as a Clinical Professor, Editor, and President of TCM societies, and he actively shapes global standards in acupuncture and TCM practices. His experience extends to editing roles in prominent scientific journals, further demonstrating his impact on academic and clinical research communities. Moreover, his leadership in major TCM organizations and contribution to Chinese medicine education worldwide underscores his dedication to advancing medical science.
ย ย ย Education
Dr. Yang’s academic journey began at Zhejiang Chinese Medical University, where he earned his MD in Traditional Chinese Medicine. He furthered his studies at Nanjing University of Chinese Medicine, completing a masterโs degree in Medical Science. His dedication to medical research led him to Kanazawa Medical University in Japan, where he earned a PhD focusing on lung injury and repair. Through his academic progression, Dr. Yang gained a strong foundation in traditional and modern medicine, enabling a profound understanding of integrative health practices. His extensive licensure includes certifications in Acupuncture and Oriental Medicine by the State Medical Board of Ohio, and he holds a Diplomate in both Acupuncture and Chinese Herbology from the NCCAOM, solidifying his credentials in Traditional Chinese Medicine and allowing him to practice and teach extensively across continents.
ย ย Experience
Dr. Yang has held numerous positions worldwide, including Professor and Doctoral Supervisor at Macau University of Science and Technology and Clinical Professor at Ohio University. He serves as a guest editor for multiple scientific journals and holds visiting professor roles in Canada and the United States. He has worked extensively with global organizations such as the World Federation of Chinese Medicine Societies, serving as Vice Chairman on committees for both Endocrine and Digestion research. As the Chief Acupuncturist and owner of Acupuncture Wellness Center of Cincinnati and Mason, Dr. Yang combines his clinical expertise with research initiatives, significantly impacting both patient care and academic communities.
ย ย Awards and Honors
Dr. Yangโs dedication to Traditional Chinese Medicine has earned him numerous accolades, including the title of Distinguished Clinical Expert by the Swiss University of Traditional Chinese Medicine. He has been recognized for his editorial contributions as Associate Editor for leading journals, including the New England Journal of Traditional Chinese Medicine. His influence extends to various TCM associations, serving as Vice President of the American TCM Association and American Association of Chinese Herbs. Dr. Yangโs contributions to integrative medicine and his role as an academic advisor to international institutes underscore his impact and dedication to advancing Traditional Chinese Medicine.
ย ย Research Focus
Dr. Yangโs research integrates Traditional Chinese Medicine with modern medical sciences, focusing on the effects of acupuncture and herbal medicine on chronic diseases, including lung injury, endocrinology, and internal medicine. His studies in gene therapy and cancer drug targeting have led to numerous publications in high-impact journals. He is particularly interested in the dose-response relationship within herbal prescriptions, aiming to enhance the efficacy of TCM treatments. As a research scientist and clinical professor, Dr. Yang continues to advance therapeutic interventions that bridge Eastern and Western practices, fostering a holistic approach to healthcare.
Publication Top Notes
Title: The transcription factor gene Nfib is essential for both lung maturation and brain development
Cited by: 349
Title: Atractylenolide III ameliorates cerebral ischemic injury and neuroinflammation associated with inhibiting JAK2/STAT3/Drp1-dependent mitochondrial fission in microglia
Cited by: 121
Title: The most commonly treated acupuncture indications in the United States: a cross-sectional study
Cited by: 102
Title: Nuclear factor I/thyroid transcription factor 1 interactions modulate surfactant protein C transcription
Cited by: 81
Title: Schaftoside ameliorates oxygen glucose deprivation-induced inflammation associated with the TLR4/Myd88/Drp1-related mitochondrial fission in BV2 microglia cells